90Y microsphere therapy: does 90Y PET/CT imaging obviate the need for 90Y Bremsstrahlung SPECT/CT imaging?
In Nuclear Medicine Communications
By: Zade AA.
Contributor(s): Shetty N | Kulkarni SS | Agrawal AR | Shah SA | Purandare NC | Rangarajan V | .
Material type:
Item type | Current location | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|
![]() |
Tata Memorial Hospital | Available | AR14680 |
BACKGROUND: Transarterial radioembolization using Y microspheres is a novel therapeutic option for inoperable hepatic malignancies. As these spheres are radiolucent, real-time assessment of their distribution during the infusion process under fluoroscopic guidance is not possible. Bremsstrahlung radiations arising from 90Y have conventionally been used for imaging its biodistribution. Recent studies have proved that sources of 90Y also emit positrons, which can further be used for PET/computed tomography (CT) imaging. This study aimed to assess the feasibility of 90Y PET/CT imaging in evaluating microsphere distributions and to compare its findings with those of Bremsstrahlung imaging.
MATERIALS AND METHODS: Thirty-five sessions of 90Y microsphere transarterial radioembolization were performed on 30 patients with hepatic malignancies. 90Y PET/CT imaging was performed within 3 h of therapy. Bremsstrahlung imaging was also performed for each patient. The imaging findings were compared for concordance in th
There are no comments for this item.